WHO ICTRP trial
Autologous punch grafting in vitiligo patients: the effect of punchdepth and…
NL-OMON35887 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON35887 |
|---|---|
| Public title | Autologous punch grafting in vitiligo patients: the effect of punchdepth and punchsize |
| Scientific title | Autologous punch grafting in vitiligo patients: the effect of punchdepth and punchsize - Punch grafting techniques in vitiligo |
| Primary sponsor | Academisch Medisch Centrum |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | Netherlands |
| Conditions | leucoderma;10035023;leucoderma |
| Interventions | Both the donorsite and recipient site first will be treated with a local anaesthetic of Lidocain 2% with adrenaline. The punchgrafts will be taken from the depigmented acceptor region to prepare this acceptor site for transplantation. Also… |
| Registration date | Jul 21, 2011 |
| Target size | 35 |
| Secondary IDs | NL36222.018.11 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: